XML 69 R55.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders’ Deficiency (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Summary of Restricted Stock Award Activity

A summary of the restricted stock award activity during the year ended December 31, 2022 is as follows:

 

  

Number of

Shares

  

Weighted

Average

Grant-Date

Fair Value

 
Restricted stock awards outstanding at January 1, 2022   194,806   $        16.94 
Vested   (97,403)   (16.94)
Restricted stock awards outstanding at December 31, 2022   97,403    16.94 
Summary of Warrant Activity

A summary of the Financing Warrants activity during the year ended December 31, 2022 is as follows:

 

           Weighted 
           Average 
       Weighted   Remaining 
   Number   Average   Contractual 
   of   Exercise   Life 
   Shares   Price   (in Years) 
Financing Warrants outstanding at January 1, 2022   116,118   $13.20    2.94 
Expired   (8,162)   35.22      
Financing Warrants outstanding at December 31, 2022   107,956    10.61    1.32 
Financing Warrants exercisable at December 31, 2022   107,956    10.61    1.32 
Schedule of Common Stock Financing Warrants Outstanding and Exercisable

The Financing Warrants outstanding and exercisable classified within the statement of stockholders’ deficiency as of December 31, 2022 are summarized as follows:

 

   Exercise Price   Expiration Date  Total Exercisable (Shares) 
Strome Warrants  $11.00   June 15, 2023   68,182 
B. Riley Warrants   7.26   October 18, 2025   39,774 
Total outstanding and exercisable           107,956